Abstract:Objective To analyze the expression and clinical significance of miR-183-5p in patients with atherosclerosis.Methods A total of 103 atherosclerotic patients diagnosed by angiography admitted to Sichuan Provincial People's Hospital from January 2021 to August 2022 were selected as the study group, and 90 age-matched healthy people undergoing health checkup in the hospital during the same period were selected as the healthy group. The expression level of miR-183-5p in the serum of the two groups was detected by real-time fluorescence quantitative polymerase chain reaction (qRT-PCR), and the diagnostic value of serum miR-183-5p for atherosclerosis was determined with the receiver operating characteristic curve (ROC curve).Results The relative expression of serum miR-183-5p in the study group was higher than that in the healthy group (P < 0.05). Within the study group, the relative expression of serum miR-183-5p in those with high Gensini score was higher than that in those with low Gensini score (P < 0.05). Pearson correlation analysis showed that the relative expression of miR-183-5p was positively correlated with the level of C-reactive protein (CRP), carotid intima-media thickness (CIMT) and Gensini scores (r = 0.664, 0.571 and 0.712, all P < 0.05). The ROC curve analysis revealed that the optimal cut-off value of miR-183-5p was 2.08 for diagnosing atherosclerosis, with the sensitivity and specificity being 87.8% (95% CI: 0.832, 0.924) and 91.6% (95% CI: 0.877, 0.955), respectively.Conclusions Serum miR-183-5p is highly expressed in patients with atherosclerosis, and it can help distinguish the degree of coronary artery stenosis and can be established as an important biomarker for clinical diagnosis and prognosis evaluation of atherosclerosis.